Wood, R., Arasteh, K., Stellbrink, H., Teofilo, E., Raffi, F., Pollard, R. B., . . . Naderer, O. J. (2004). Six-Week Randomized Controlled Trial To Compare the Tolerabilities, Pharmacokinetics, and Antiviral Activities of GW433908 and Amprenavir in Human Immunodeficiency Virus Type 1-Infected Patients. American Society for Microbiology.
Chicago Style CitationWood, Robin, et al. Six-Week Randomized Controlled Trial To Compare the Tolerabilities, Pharmacokinetics, and Antiviral Activities of GW433908 and Amprenavir in Human Immunodeficiency Virus Type 1-Infected Patients. American Society for Microbiology, 2004.
Cita MLAWood, Robin, et al. Six-Week Randomized Controlled Trial To Compare the Tolerabilities, Pharmacokinetics, and Antiviral Activities of GW433908 and Amprenavir in Human Immunodeficiency Virus Type 1-Infected Patients. American Society for Microbiology, 2004.